科前生物(688526.SH)：上半年净利润2.2亿元 同比增加44.09%

Core Viewpoint - The company, Keqian Bio (688526.SH), reported a significant increase in both revenue and net profit for the first half of the year, indicating strong operational performance and growth potential [1] Financial Performance - The company achieved operating revenue of 487.29 million yuan, representing a year-on-year increase of 21.67% [1] - The net profit attributable to the parent company was 219.90 million yuan, reflecting a year-on-year increase of 44.09% [1]